Výsledky vyhledávání - Cesare Gridelli
- Zobrazuji výsledky 1 - 20 z 47
- Přejít na další stránku
-
1
-
2
-
3
-
4
Immunotherapy in the first-line treatment of elderly patients with advanced non-small-cell lung cancer: results of an International Experts Panel Meeting by the Italian Association... Autor Cesare Gridelli, Solange Peters, Vamsidhar Velcheti, Ilaria Attili, Filippo de Marinis
Vydáno 2023Revisão -
5
-
6
-
7
-
8
-
9
-
10
Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies Autor Jessica Davies, Manali I. Patel, Cesare Gridelli, Filippo de Marinis, Daniel Waterkamp, Margaret McCusker
Vydáno 2017Revisão -
11
-
12
First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association... Autor Cesare Gridelli, Solange Peters, Tony Mok, Patrick M. Forde, Martin Reck, Ilaria Attili, Filippo de Marinis
Vydáno 2021Revisão -
13
Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology Autor Cesare Gridelli, Andrea Ardizzoni, Massimo Barberis, Federico Cappuzzo, Francesca Casaluce, Romano Danesi, Giancarlo Troncone, Filippo de Marinis
Vydáno 2017Revisão -
14
Erlotinib in Advanced Non-small Cell Lung Cancer: Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Study Autor Martin Reck, Nico van Zandwijk, Cesare Gridelli, Zoltán Balikó, Danny Rischin, Simon Allan, Maciej Krzakowski, David F. Heigener
Vydáno 2010Artigo -
15
Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology Autor Athanasios Pallis, Cesare Gridelli, Ulrich Wedding, Corinne Faivre‐Finn, Paolo Veronesi, Michael T. Jaklitsch, Andrea Luciani, Mary O’Brien
Vydáno 2014Artigo -
16
Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer Autor Massimo Di Maïo, Francesco Perrone, Paolo Chiodini, Ciro Gallo, Carlos Camps, Wolfgang Schuette, Élisabeth Quoix, Chun-Ming Tsai, Cesare Gridelli
Vydáno 2007Revisão -
17
EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts’ opinion for the treatment of non-small-cell lung cancer in an elderl... Autor Athanasios Pallis, Cesare Gridelli, Jan P. van Meerbeeck, Laurent Greillier, Ulrich Wedding, Didier Lacombe, John J. Welch, Chandra P. Belani, Matti Aapro
Vydáno 2009Revisão -
18
Treatment of Elderly Patients With Non–Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology Autor Cesare Gridelli, Lodovico Balducci, Fortunato Ciardiello, Massimo Di Maïo, Enriqueta Felip, Corey J. Langer, Rogério Lilenbaum, Federica Perrone, Suresh Senan, Filippo de Marinis
Vydáno 2015Revisão -
19
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel Autor Cesare Gridelli, Andrea Ardizzoni, Thierry Le Chevalier, C. Manegold, Federica Perrone, N. Thatcher, Nico van Zandwijk, Massimo Di Maïo, Olga Martelli, Filippo de Marinis
Vydáno 2004Revisão -
20
Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer Autor Massimo Di Maïo, Paolo Chiodini, Vassilis Georgoulias, Dora Hatzidaki, Koji Takeda, Floris M Wachters, Vittorio Gebbia, Egbert F. Smit, Alessandro Morabito, Ciro Gallo, Francesco Perrone, Cesare Gridelli
Vydáno 2009Revisão
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Lung cancer
Oncology
Cancer
Chemotherapy
Clinical trial
Cisplatin
Surgery
Epidermal growth factor receptor
Erlotinib
Confidence interval
Intensive care medicine
Nursing
Adverse effect
Docetaxel
Gastroenterology
Gemcitabine
Hazard ratio
Pathology
Phases of clinical research
Quality of life (healthcare)
Randomized controlled trial
Immunotherapy
Pemetrexed
Performance status
Vinorelbine
Biology
Clinical endpoint
Crizotinib